Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
BJUI Compass
|
February 17, 2025
Method to determine the nadir PSA following partial gland ablation
Nelson N Stone, Vassilios Skouteris, Rendi Shu, et al.
Brachytherapy
|
April 6, 2004
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy
Nelson N Stone, Suzanne Hong, Yeh-Chi Lo, et al.
The Journal of Urology
|
December 17, 2009
Impact of hormonal therapy on intermediate risk prostate cancer treated with combination brachytherapy and external beam irradiation
Richard G Stock, Swati Yalamanchi, Swati Yamalachi, et al.
Brachytherapy
|
November 26, 2010
Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy
Todd J Carpenter, Kevin Forsythe, Johnny Kao, et al.
The Prostate
|
January 5, 2002
Increased serum insulin associated with increased risk of prostate cancer recurrence
Steven Lehrer, Edward J Diamond, Sharodka Stagger, et al.
The Journal of Urology
|
November 26, 2011
Factors influencing urinary symptoms 10 years after permanent prostate seed implantation
Nelson N Stone, Naamit Kurshan Gerber, Seth Blacksburg, et al.
Brachytherapy
|
February 6, 2022
Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy
Nelson N Stone, Pamela D Unger, Rendi Sheu, et al.
The Journal of Urology
|
December 21, 2010
Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy
Nelson N Stone, Mariana M Stone, Barry S Rosenstein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2004
Combined modality treatment in the management of high-risk prostate cancer
Richard G Stock, Oren Cahlon, Jamie A Cesaretti, et al.
Brachytherapy
|
July 28, 2022
Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer
Zeynep G Gul, Rollin Say, Vassilios M Skouteris, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
BJUI Compass
|
February 17, 2025
Method to determine the nadir PSA following partial gland ablation
Nelson N Stone, Vassilios Skouteris, Rendi Shu, et al.
Brachytherapy
|
April 6, 2004
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy
Nelson N Stone, Suzanne Hong, Yeh-Chi Lo, et al.
The Journal of Urology
|
December 17, 2009
Impact of hormonal therapy on intermediate risk prostate cancer treated with combination brachytherapy and external beam irradiation
Richard G Stock, Swati Yalamanchi, Swati Yamalachi, et al.
Brachytherapy
|
November 26, 2010
Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy
Todd J Carpenter, Kevin Forsythe, Johnny Kao, et al.
The Prostate
|
January 5, 2002
Increased serum insulin associated with increased risk of prostate cancer recurrence
Steven Lehrer, Edward J Diamond, Sharodka Stagger, et al.
The Journal of Urology
|
November 26, 2011
Factors influencing urinary symptoms 10 years after permanent prostate seed implantation
Nelson N Stone, Naamit Kurshan Gerber, Seth Blacksburg, et al.
Brachytherapy
|
February 6, 2022
Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy
Nelson N Stone, Pamela D Unger, Rendi Sheu, et al.
The Journal of Urology
|
December 21, 2010
Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy
Nelson N Stone, Mariana M Stone, Barry S Rosenstein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2004
Combined modality treatment in the management of high-risk prostate cancer
Richard G Stock, Oren Cahlon, Jamie A Cesaretti, et al.
Brachytherapy
|
July 28, 2022
Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer
Zeynep G Gul, Rollin Say, Vassilios M Skouteris, et al.
Page
of 12